Impact of diabetes mellitus and hemoglobin A1c level on outcomes among Chinese patients with acute coronary syndrome

Clin Cardiol. 2020 Jul;43(7):723-731. doi: 10.1002/clc.23373. Epub 2020 May 19.

Abstract

Background: The impact of different glycemic control conditions on in-hospital and long-term outcomes among patients with acute coronary syndrome (ACS) is less well defined.

Hypothesis: Diabetes mellitus (DM) with different admission hemoglobin A1c (HbA1c) levels (different glycemic control) could affect outcomes among Chinese patients hospitalized as ACS.

Methods: We categorized 8961 Chinese ACS patients into one of the following three groups: "no DM" (group 1, n = 3773; no DM history and admission HbA1c < 6.5%), "DM with optimal control"(group 2, n = 2241; DM with admission HbA1c < 7.0%), "DM with suboptimal control"(group 3, n = 2947; DM with admission HbA1c ≥ 7.0%). The primary outcome was in-hospital major adverse cardiovascular events (MACEs). 6098 patients were followed for a median of 3.85 years. Adjusted associations of these three groups with in-hospital MACEs and long-term mortality were determined.

Results: DM with suboptimal control (group 3) was associated with greater in-hospital MACEs (OR 1.46, 95% CI 1.17-1.81, P = .001) than "no DM" (group 1). DM patients (group 2 and group 3) also had higher in-hospital MACEs (OR 1.42, 95% CI 1.16-1.73, P = .001) than "no DM" patients (group 1). It showed no significantly different in-hospital MACEs between optimal (group 2) and suboptimal (group 3) control group (OR 1.06, 95% CI 0.84-1.34, P = .63). Both optimal control (group 2) and suboptimal control (group 3) had a higher long-term mortality (HR 1.26, 95% CI 1.02-1.56, P = .03; HR 1.42, 95% CI 1.16-1.73, P = .001).

Conclusions: ACS patients with DM were associated with higher in-hospital MACEs and long-term mortality. Moreover, lower HbA1c level seems to have limited impact on cardiovascular events and long-term mortality in this high-risk population.

Keywords: acute coronary syndrome; diabetes mellitus; hemoglobin A1c.

MeSH terms

  • Acute Coronary Syndrome / blood
  • Acute Coronary Syndrome / epidemiology*
  • Acute Coronary Syndrome / physiopathology
  • Aged
  • Biomarkers / blood
  • Diabetes Complications / blood
  • Diabetes Complications / epidemiology*
  • Diabetes Complications / physiopathology
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / epidemiology*
  • Diabetes Mellitus / physiopathology
  • Female
  • Glycated Hemoglobin / analysis*
  • Humans
  • Male
  • Middle Aged
  • Patient Admission / statistics & numerical data*
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Time Factors

Substances

  • Biomarkers
  • Glycated Hemoglobin A